Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine

Behavioural Pharmacology

Volumn 10, Issue 6-7, 1999, Pages 691-697

  Irvine, E E ^a   Cheeta, S ^a   File, S E ^a,b  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Anxiety; Nicotine; Rat; Social interaction; Tolerance; Withdrawal

Indexed keywords

NICOTINE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG TOLERANCE; DRUG WITHDRAWAL; LOCOMOTION; MALE; NONHUMAN; RAT; SOCIAL INTERACTION; TRANQUILIZING ACTIVITY;

EID: 0033375254     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199911000-00016     Document Type: Article

References (32)

1. Brioni JD, O'Neill AB, Kim DJB, Decker MW (1993). Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur J Pharmacol 283:1-8.
2. Brioni JD, O'Neill AB, Kim DJB, Buckley MJ, Decker MW, Arneric SP (1994). Anxiolytic-like effects of the novel cholinergic channel activator ABT-418. J Pharmacol Exp Ther 271:353-361.
3. Cao W, Burkholder T, Wilkins L, Collins AC (1993). A genetic comparison of the behavioral actions of ethanol and nicotine in the mirrored chamber. Pharmacol Biochem Behav 45:803-809.
4. Clarke PBS (1987). Nicotine and smoking: A perspective from animal studies. Psychopharmacology 92:135-143.
5. Clarke PBS, Kumar R (1983a). The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br J Pharmacol 78:329-337.
6. Clarke PBS, Kumar C (1983b). Characterization of the locomotor stimulant action of nicotine in tolerant rats. Br J Pharmacol 80:587-594.
7. Costall B, Kelly ME, Naylor RJ, Onaivi ES, Wong EH, Smith WL et al. (1989). The actions of nicotine and cocaine in a mouse model of anxiety. Pharmacol Biochem Behav 33:197-203.
8. Costall B, Jones BJ, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB (1990). Site of action of ondansetron to inhibit withdrawal from drugs of abuse. Pharmacol Biochem Behav 36:97-104.
9. File SE (1980). The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Meth 2:219-238.
10. File SE, Baldwin HA, Aranko K (1987). Anxiogenic effects in benzodiazepine withdrawal are linked to the development of tolerance. Brain Res Bull 19:607-610.
11. File SE, Kenny PJ, Ouagazzal A-M (1998a). Bimodal modulation by nicotine of anxiety in the social interaction test: Role of dorsal hippocampus. Behav Neurosci 112:1-7.
12. File SE, Ouagazzal A-M, Kenny PJ (1998b). Hippocampal and septal nicotinic modulation of anxiety reveals differences among animal tests. Soc. Neurosci Abstr 24:1427.
13. Goldberg SR, Spealman RD, Risner ME, Henningfield JE (1983). Control of behaviour by intravenous nicotine injections in laboratory animals. Pharmacol Biochem Behav 19:1011-1020.
14. Helton DR, Modlin DL, Tizzano JP, Rasmussen K (1993). Nicotine withdrawal: a behavioural assessment using schedule controlled responding, locomotor activity, and sensoriomotor reactivity. Psychopharmacology 113:205-210.
15. Herberg LJ, Montgomery AMJ, Rose IC (1993). Tolerance and sensitization to stimulant and depressant effects of nicotine in intracranial self-stimulation in the rat. Behav Pharmacol 4:419-427.
16. Ksir CJ, Hakan RL, Kellar KJ (1987). Chronic nicotine and locomotor activity: influences of exposure and test dose. Psychopharmacology 92:25-29.
17. Malin DH, Lake RJ, Paige N-M, Roberts LK, Lanier JG, Carter VA et al. (1992). Rodent model of nicotine abstinence syndrome. Pharmacol Biochem Behav 43:779-784.
18. Marks MJ, Burch JB, Collins AC (1983). Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther 226:817-825.
19. Marks MJ, Stitzel JA, Collins AC (1985).Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther 235:619-628.
20. Marks MJ, Grady SR, Collins AC (1993). Downregulation of nicotinic receptor function after chronic nicotine infusion. J Pharmacol Exp Ther 266:1268-1276.
21. Morrison CF (1969). The effects of nicotine on punished behaviour. Psychopharmacologia 14:221-232.
22. Olausson P, Engel JA, Soderpalm B (1999). Behavioural scnsitization to nicotine is associated with behavioural disinhibition; counteraction by citalopram. Psycopharmacology 142:111-119.
23. Ouagazzal A-M, Kenny PJ, File SE (1999). Modulation of anxiety on trials 1 and 2 in the elevated plus-maze after systemic and hippocampal administration of nicotine. Psychopharmacology 144:54-60.
24. Perkins KA, Grobe JE, Fonte C, Goettler J, Caggiula AR, Reynolds WA et al. (1994). Chronic and acute tolerance to subjective, behavioural and cardiovascular effects of nicotine in humans. J Pharmacol Exp Ther 270:628-638.
25. 1A agonist 8-OH-DPAT. Psychopharmacology 133:343-346.
26. Rasmussen K, Kallman MJ, Helton DR (1997). Serotonin-1A antagonists attenuate the effects of nicotine withdrawal on the auditory startle response. Synapse 27:145-152.
27. Shoaib M, Schindler CW, Goldberg SR, Pauly JR (1997). Behavioural and biochemical adaptations to nicotine in rats: influence of MK801, an NMDA receptor anatgonist. Psychopharmacology 134:121-130.
28. 3H)acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem 45:427-433.
29. Stolerman IP, Fink R, Jarvik ME (1973). Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacologia 30:329-342.
30. Stolerman IP, Bunker P, Jarvik ME (1974). Nicotine tolerance in rats; role of dose and dose interval. Psychopharmacologia 34:317-324.
31. Takada K, Barrett JE, Allen MS, Cook JM and Katz JL (1992) Punishment of schedule-controlled behaviour with β-carboline injections: Antagonism and comparisons with other compounds. J Pharmacol Exp Ther 261:138-145.
32. Vale AL, Green S (1986). Effects of chlordiazepoxide, nicotine and d-amphetamine in the rat potentiated startle model of anxiety. Behav Pharmacol 7:138-143.